We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.
You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Please get in touch with ann.wales3@nhs.scot with any questions.
Avoid opiates and restrict acute medication to 2 days a week.
When starting acute treatment healthcare professionals should warn patients about the risk of developing medication-overuse headache.
Aspirin 900 mg
Ibuprofen 400–600 mg
Triptans:
Paracetamol (1,000 mg) can be considered in those unable to take other therapies.
Add antiemetic: metoclopramide 10 mg or prochloperazine 10 mg. Either an oral or parenteral formulation can be used.
Metaclopramide should not be used regularly due to the risk of extrapyramidal side effects.
Consider nasal zolmitriptan or subcutaneous sumatriptan.
Triptans other than sumatriptan.
Consider combination therapy using sumatriptan (50–85 mg) and naproxen (500 mg).
The dose for sumatriptan corresponds to the doses used in the clinical trials. In the UK sumatriptan is available and used in 50 mg and 100 mg doses.
Due to its safety profile, paracetamol is first choice for the short-term relief of mild-to-moderate headache during any trimester of pregnancy.
Consider sumatriptan in all stages of pregnancy. The risk associated with use should be discussed before commencing treatment.
Aspirin, in doses for migraine, is not an analgesic of choice during pregnancy and should not be used in the third trimester of pregnancy.
Pharmacological management of migraine (SIGN)